FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4296323743> ?p ?o ?g. }

• W4296323743 endingPage "e0271663" @default.
• W4296323743 startingPage "e0271663" @default.
• W4296323743 abstract "Thrombosis is common in subjects suffering from cardiovascular diseases (CVD) and cancer. Hypercoagulation plays a pivotal role in the pathophysiology of thrombosis. Therefore, the inactivation of thrombin, the key enzyme in coagulation, is tightly regulated via antithrombin (AT). AT deficiency is related to thrombosis and cardiovascular death. In this study we investigated the association between AT levels and mortality, in particularly cardiovascular-related and cancer-related death in the general population.We studied the association of AT levels and mortality in a prospective cohort sampled from the general Italian population (n = 19,676). AT levels were measured in the baseline samples, and mortality was recorded during a median follow-up period of 8.2 years. Cox regression was performed to investigate the association of all-cause, CVD-related and cancer-related mortality with variations in AT levels.In total, 989 subjects died during follow-up, of which 373 subjects of CVD and 353 of cancer-related causes. Cox analysis revealed that, after adjustment for age, sex, current smoking, BMI, diabetes, hypertension, hypercholesterolemia, history of cardiovascular disease, history of cancer, vitamin K antagonists, antiplatelet medication, heparin and oral contraceptives AT levels were not associated with all-cause mortality (HRQ1vsQ5: 0.92, 95% CI:0.74-1.15). Interestingly, the risk of CVD-related mortality was reduced in subjects with low AT levels compared to subjects with higher AT levels, after adjustment for age and sex and other confounders did not change the association (HRQ1vsQ5: 0.64, 95% CI:0.44-0.91). Moreover, low AT levels were associated with increased cancer mortality in a fully adjusted model (HRQ1vsQ2-5: 1.26, 95% CI:0.88-1.81).Low AT levels are associated to a lower risk of fatal cardiovascular events in the general population, regardless of age, sex and medication use. In contrast, low AT levels are associated with lower cancer survival. For the first time we show that AT levels lower than the normal range in the general population, even before the development or diagnosis of cancer, are associated with an elevated risk of cancer death." @default.
• W4296323743 created "2022-09-20" @default.
• W4296323743 creator A5010174979 @default.
• W4296323743 creator A5010557706 @default.
• W4296323743 creator A5025599058 @default.
• W4296323743 creator A5027231306 @default.
• W4296323743 creator A5033092400 @default.
• W4296323743 creator A5033370052 @default.
• W4296323743 creator A5047508408 @default.
• W4296323743 creator A5069797729 @default.
• W4296323743 creator A5072766555 @default.
• W4296323743 creator A5080383375 @default.
• W4296323743 creator A5039233740 @default.
• W4296323743 date "2022-09-19" @default.
• W4296323743 modified "2023-09-26" @default.
• W4296323743 title "Low antithrombin levels are associated with low risk of cardiovascular death but are a risk factor for cancer mortality" @default.
• W4296323743 cites W1965933162 @default.
• W4296323743 cites W1966341829 @default.
• W4296323743 cites W1966843150 @default.
• W4296323743 cites W1975231278 @default.
• W4296323743 cites W1978080273 @default.
• W4296323743 cites W1981446108 @default.
• W4296323743 cites W1985891284 @default.
• W4296323743 cites W2014352220 @default.
• W4296323743 cites W2015263152 @default.
• W4296323743 cites W2023419977 @default.
• W4296323743 cites W2024789639 @default.
• W4296323743 cites W2026263242 @default.
• W4296323743 cites W2030743764 @default.
• W4296323743 cites W2055574241 @default.
• W4296323743 cites W2067755939 @default.
• W4296323743 cites W2072730608 @default.
• W4296323743 cites W2099844353 @default.
• W4296323743 cites W2102019153 @default.
• W4296323743 cites W2115509671 @default.
• W4296323743 cites W2122540770 @default.
• W4296323743 cites W2132874181 @default.
• W4296323743 cites W2143077029 @default.
• W4296323743 cites W2157446158 @default.
• W4296323743 cites W2171134269 @default.
• W4296323743 cites W2197375803 @default.
• W4296323743 cites W2256536249 @default.
• W4296323743 cites W2324213097 @default.
• W4296323743 cites W260790831 @default.
• W4296323743 cites W2610992815 @default.
• W4296323743 cites W2734498030 @default.
• W4296323743 cites W2745668208 @default.
• W4296323743 cites W2750066127 @default.
• W4296323743 cites W2946803004 @default.
• W4296323743 cites W3017333432 @default.
• W4296323743 cites W3045469049 @default.
• W4296323743 cites W4210655622 @default.
• W4296323743 cites W4231867497 @default.
• W4296323743 doi "https://doi.org/10.1371/journal.pone.0271663" @default.
• W4296323743 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36121817" @default.
• W4296323743 hasPublicationYear "2022" @default.
• W4296323743 type Work @default.
• W4296323743 citedByCount "0" @default.
• W4296323743 crossrefType "journal-article" @default.
• W4296323743 hasAuthorship W4296323743A5010174979 @default.
• W4296323743 hasAuthorship W4296323743A5010557706 @default.
• W4296323743 hasAuthorship W4296323743A5025599058 @default.
• W4296323743 hasAuthorship W4296323743A5027231306 @default.
• W4296323743 hasAuthorship W4296323743A5033092400 @default.
• W4296323743 hasAuthorship W4296323743A5033370052 @default.
• W4296323743 hasAuthorship W4296323743A5039233740 @default.
• W4296323743 hasAuthorship W4296323743A5047508408 @default.
• W4296323743 hasAuthorship W4296323743A5069797729 @default.
• W4296323743 hasAuthorship W4296323743A5072766555 @default.
• W4296323743 hasAuthorship W4296323743A5080383375 @default.
• W4296323743 hasBestOaLocation W42963237431 @default.
• W4296323743 hasConcept C121608353 @default.
• W4296323743 hasConcept C126322002 @default.
• W4296323743 hasConcept C134018914 @default.
• W4296323743 hasConcept C188816634 @default.
• W4296323743 hasConcept C201903717 @default.
• W4296323743 hasConcept C2779134260 @default.
• W4296323743 hasConcept C2908647359 @default.
• W4296323743 hasConcept C29374701 @default.
• W4296323743 hasConcept C555293320 @default.
• W4296323743 hasConcept C71924100 @default.
• W4296323743 hasConcept C99454951 @default.
• W4296323743 hasConceptScore W4296323743C121608353 @default.
• W4296323743 hasConceptScore W4296323743C126322002 @default.
• W4296323743 hasConceptScore W4296323743C134018914 @default.
• W4296323743 hasConceptScore W4296323743C188816634 @default.
• W4296323743 hasConceptScore W4296323743C201903717 @default.
• W4296323743 hasConceptScore W4296323743C2779134260 @default.
• W4296323743 hasConceptScore W4296323743C2908647359 @default.
• W4296323743 hasConceptScore W4296323743C29374701 @default.
• W4296323743 hasConceptScore W4296323743C555293320 @default.
• W4296323743 hasConceptScore W4296323743C71924100 @default.
• W4296323743 hasConceptScore W4296323743C99454951 @default.
• W4296323743 hasFunder F4320332718 @default.
• W4296323743 hasFunder F4320333065 @default.
• W4296323743 hasIssue "9" @default.
• W4296323743 hasLocation W42963237431 @default.
• W4296323743 hasLocation W42963237432 @default.

• next